Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
2.280
-0.020 (-0.87%)
May 30, 2025, 3:12 PM - Market open
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $145.98 million as of May 30, 2025. Its market cap has decreased by -68.74% in one year.
Market Cap
145.98M
Enterprise Value
-13.08M
1-Year Change
-68.74%
Ranking
Category
Stock Price
$2.28
Market Cap Chart
Since June 19, 2014, Larimar Therapeutics's market cap has decreased from $410.90M to $145.98M, a decrease of -64.47%. That is a compound annual growth rate of -9.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 147.30M | -40.34% |
| Dec 31, 2024 | 246.90M | 23.57% |
| Dec 29, 2023 | 199.80M | 11.81% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | 328.80M | 692.29% |
| Dec 31, 2019 | 41.50M | -77.26% |
| Dec 31, 2018 | 182.50M | 43.70% |
| Dec 29, 2017 | 127.00M | 46.14% |
| Dec 30, 2016 | 86.90M | -49.27% |
| Dec 31, 2015 | 171.30M | -75.54% |
| Dec 31, 2014 | 700.30M | 70.43% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 651.06B |
| Johnson & Johnson | 368.73B |
| AbbVie | 328.06B |
| Novo Nordisk | 313.75B |
| UnitedHealth Group | 267.61B |
| Abbott Laboratories | 231.29B |
| Novartis AG | 221.98B |
| AstraZeneca | 219.74B |